A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study
Nakayama, Norisuke, Sato, Atsushi, Tanaka, Soichi, Shimada, Ken, Konishi, Kazuo, Sasaki, Eisaku, Hibi, Kenji, Ichikawa, Hiroko, Kikuchi, Yoshinori, Sakuyama, Toshikazu, Sekikawa, Takashi, Hayashi, KazVolume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0239-1
Date:
August, 2015
File:
PDF, 597 KB
english, 2015